Cargando…
Complete heart block associated with Remdesivir in COVID-19: a case report
BACKGROUND: Since the pandemic began in 2020, Remdesivir has been widely used for the treatment of coronavirus disease-2019 (COVID-19). Here, we describe a case of a patient with COVID-19 who developed transient complete atrioventricular (AV) block and bradycardia after initiating treatment with Rem...
Autores principales: | Selvaraj, Vijairam, Bavishi, Chirag, Patel, Simaben, Dapaah-Afriyie, Kwame |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247739/ https://www.ncbi.nlm.nih.gov/pubmed/34222786 http://dx.doi.org/10.1093/ehjcr/ytab200 |
Ejemplares similares
-
Association of Treatment with Remdesivir and 30-day Hospital Readmissions in Patients Hospitalized with COVID-19
por: Finn, Arkadiy, et al.
Publicado: (2022) -
Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials
por: Selvaraj, Vijairam, et al.
Publicado: (2021) -
COVID-19-induced granulomatosis with polyangiitis
por: Selvaraj, Vijairam, et al.
Publicado: (2021) -
Efficacy of remdesivir for hospitalized COVID-19 patients with end stage renal disease
por: Selvaraj, Vijairam, et al.
Publicado: (2022) -
Severe multisystem inflammatory syndrome in a vaccinated adult with COVID-19
por: Selvaraj, Vijairam, et al.
Publicado: (2022)